ARMY Awards $106,300,002 Contract to Ology Bioservices
Ology Bioservices Inc., Alachua, Florida, was awarded a $106,300,002 firm-fixed-price contract to reserve production capacity of approximately 186,840,000 doses to satisfy an urgent need for domestic aseptic fill and finish manufacturing of critical vaccines and therapeutics in support of the Operation Warp Speed response to the COVID-19 pandemic. Bids were solicited via the internet with eight received. Work will be performed in Alachua, Florida, with an estimated completion date of Aug. 10, 2021. Reimbursable fiscal 2020 Army research, development, test and evaluation funds backed by the fiscal 2020 Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services, in the amount of $53,150,001 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911QY-20-C-0101). (Awarded Aug. 17, 2020)
Ology Bioservices is a private, American biopharmaceutical company headquartered in Alachua, Florida. The company was founded in 1999 as an integrated biopharmaceutical company with a focus on development and manufacturing as well as having expertise in preclinical and clinical development, formulation optimization, and cGMP manufacturing of biopharmaceutical products and medical devices.